BSE: STAR - Strides Pharma Science Limited

Доходность за полгода: -57.9%
Дивидендная доходность: +0.05%

График акции Strides Pharma Science Limited


О компании Strides Pharma Science Limited

Strides Pharma Science Limited develops, manufactures, and sells pharmaceutical products in Africa, Australia, North America, Europe, Asia, India, and internationally. It operates through two segments, Pharmaceutical and Biopharmaceutical. The company offers pharma generics in various forms, such as tablets, hard and soft gelatin capsules, sachets, and liquids, as well as nasal spray, gels, powders, solids, ointments, and creams.

подробнее
It also develops branded generics products for the treatment of chronic therapies, including women's health, central nervous system, cardiovascular, diabetes, dermatology, and probiotics under the Renerve, Unibrol, Combiart, Duotab, and Vitafer brands; and anti-retroviral, anti-malarial, anti-tuberculosis, Hepatitis, and other infectious disease drug segments for institutional business. The company was formerly known as Strides Shasun Limited and changed its name to Strides Pharma Science Limited in July 2018. Strides Pharma Science Limited was incorporated in 1990 and is headquartered in Bengaluru, India.

ISIN INE939A01011
Industry Pharmaceuticals
Sector Health Care
Валюта inr
Валюта отчета inr
Див.доход ао 0.0512
Дивиденд ао 1.14
Сайт https://www.strides.com
Цена ао 586.05
Изменение цены за день: 0% (586.05)
Изменение цены за неделю: -5.67% (621.3)
Изменение цены за месяц: -11.87% (665)
Изменение цены за 3 месяца: -18.24% (716.8)
Изменение цены за полгода: -57.9% (1392.1)
Изменение цены за год: -25.74% (789.2)
Изменение цены за 3 года: +77.86% (329.5)
Изменение цены за 5 лет: +26.36% (463.8)
Изменение цены за 10 лет: 0% (586.05)
Изменение цены с начала года: -13.34% (676.3)

Недооценка

Название Значение Оценка
P/S 1.83 8
P/BV 3.44 5
P/E 0 0
EV/EBITDA 22.91 5
Итого: 5.5

Эффективность

Название Значение Оценка
ROA, % -1.13 0
ROE, % -3.26 0
Итого: 0.6667

Дивиденды

Название Значение Оценка
Div yield, % 0.0512 0.13
DSI 0.8571 8.57
Итого: 1.79

Долг

Название Значение Оценка
Debt/EBITDA 11.07 0
Итого: 5.8

Импульс роста

Название Значение Оценка
Доходность Revenue, % 43.72 6
Доходность Ebitda, % -46.65 0
Доходность EPS, % -289.02 0
Итого: 3.2

Руководитель Должность Оплата Год рождения
Mr. Arun Kumar Pillai B.Com. Founder & Executive Chairperson 60M 1961 (64 года)
Mr. Badree Komandur MD & Group CEO 44M 1972 (53 года)
Ms. Manjula Ramamurthy Compliance Officer & Company Secretary N/A
Sormistha Ghosh Group General Counsel, Chief Risk Officer & Chief Sustainability Officer N/A
Mr. C. K. Sundar Executive Vice President of Operations N/A
Mr. Kevin P. Cook Senior Vice President of Strides Pharma Inc. N/A
Mr. P. V. S. Ramaraju Chief Operating Officer N/A
Mr. Aditya Arun Kumar Executive Director of Business Development & Director
Mr. Vikesh Kumar Group CFO & Chief Investor Relations Officer 1985 (40 лет)
Ms. Surabhi Loshali Group Chief Human Resource Officer 1980 (45 лет)

Адрес: India, Bengaluru, Strides House - открыть в Google картах, открыть Яндекс картах
Сайт: https://www.strides.com